Tests tobacco substitute products for smokers living with HIV
Tests offering e-cigarettes, nicotine pouches or patches to adults with HIV who smoke.
Plain-language title generated from the registry record
Registry title: Reduce Tobacco Use in People Living With HIV in Switzerland
Key facts
- Where
- Aarau, Basel, Bern, Geneva, Lausanne, Sankt Gallen, and Zurich, SwitzerlandSee the 7 sites
Where in Switzerland
- Cantonal Hospital AarauAarau, SwitzerlandTaking people
- University Hospital BaselBasel, SwitzerlandNo longer taking part
- Inselspital BernBern, SwitzerlandTaking people
- University Hospital GenevaGeneva, SwitzerlandTaking people
- University Hospital LausanneLausanne, SwitzerlandTaking people
- Cantonal Hospital St GallenSankt Gallen, SwitzerlandTaking people
- University Hospital ZurichZurich, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Basel, Switzerland
- Trial code
- NCT06789692
- Record updated
- 2 June 2026
- Original description
The purpose of this trial is to test the effectiveness of offering a menu of different tobacco smoking substitutional products (e-cigarettes, nicotine pouches, nicotine patches in addition to usual of care) for smokers in the SHCS (Swiss HIV Cohort Study) in achieving self-reported 7-day tobacco cigarette abstinence at 6 months.Read full original descriptionShow less
Reduce Tobacco Use in People Living With HIV in Switzerland: A Pragmatic Randomized Trial Within the Swiss HIV Cohort Study
The purpose of this trial is to test the effectiveness of offering a menu of different tobacco smoking substitutional products (e-cigarettes, nicotine pouches, nicotine patches in addition to usual of care) for smokers in the SHCS (Swiss HIV Cohort Study) in achieving self-reported 7-day tobacco cigarette abstinence at 6 months.
Inclusion: Signed informed consent for the data collection and participation in the SHCS (Cohort consent); Signed informed consent to be randomized to future interventions (Randomization consent); Age 18 years or older; Smoked one or more tobacco cigarettes per day (smoking status = yes) at the time of enrolment.
Exclusion: Currently using e-cigarettes or nicotine pouches or nicotine patches; Pregnant women.